Rational design of nanocarriers for mitochondria-targeted drug delivery

Lihua Huang; Zonghao Sun; Qian Shen; Zhongxi Huang; Shuangxi Wang; Naidi Yang; Gongqiang Li; Qiong Wu; Wei Wang; Lin Li; Changmin Yu

doi:10.1016/j.cclet.2022.02.047

Rational design of nanocarriers for mitochondria-targeted drug delivery

Lihua Huang, Zonghao Sun, Qian Shen, Zhongxi Huang, Shuangxi Wang, Naidi Yang, Gongqiang Li, Qiong Wu, Wei Wang, Lin Li, Changmin Yu

柔性电子（未来科技）学院|先进材料研究院

科研成果: 期刊稿件 › 文章 › 同行评审

38 引用（Scopus）

摘要

Well-developed mitochondria-targeted nanocarriers for function regulation are highly desirable. Numerous studies have been conducted on the treatment of mitochondria-related diseases; however, further improvements are required to develop more effective drug delivery methods. Herein, we comprehensively introduce recent developments progress in rational design of mitochondria-targeted nanocarriers, and discuss the different strategies of available nanocarriers for targeting mitochondria. We also highlight the advantages and disadvantages of various carrier systems that are currently in use. Finally, perspective on new generation for mitochondria-targeted delivery systems in the emerging area of drug-based therapeutics is also discussed.

源语言	英语
页（从-至）	4146-4156
页数	11
期刊	Chinese Chemical Letters
卷	33
期	9
DOI	https://doi.org/10.1016/j.cclet.2022.02.047
出版状态	已出版 - 9月 2022

访问文件

10.1016/j.cclet.2022.02.047

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{63596a6d93dd4b23a4af085a41579087,

title = "Rational design of nanocarriers for mitochondria-targeted drug delivery",

abstract = "Well-developed mitochondria-targeted nanocarriers for function regulation are highly desirable. Numerous studies have been conducted on the treatment of mitochondria-related diseases; however, further improvements are required to develop more effective drug delivery methods. Herein, we comprehensively introduce recent developments progress in rational design of mitochondria-targeted nanocarriers, and discuss the different strategies of available nanocarriers for targeting mitochondria. We also highlight the advantages and disadvantages of various carrier systems that are currently in use. Finally, perspective on new generation for mitochondria-targeted delivery systems in the emerging area of drug-based therapeutics is also discussed.",

keywords = "Mitochondria diseases, Mitochondria target, Nanocarriers, Therapeutic drugs",

author = "Lihua Huang and Zonghao Sun and Qian Shen and Zhongxi Huang and Shuangxi Wang and Naidi Yang and Gongqiang Li and Qiong Wu and Wei Wang and Lin Li and Changmin Yu",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = sep,

doi = "10.1016/j.cclet.2022.02.047",

language = "英语",

volume = "33",

pages = "4146--4156",

journal = "Chinese Chemical Letters",

issn = "1001-8417",

publisher = "Elsevier B.V.",

number = "9",

}

TY - JOUR

T1 - Rational design of nanocarriers for mitochondria-targeted drug delivery

AU - Huang, Lihua

AU - Sun, Zonghao

AU - Shen, Qian

AU - Huang, Zhongxi

AU - Wang, Shuangxi

AU - Yang, Naidi

AU - Li, Gongqiang

AU - Wu, Qiong

AU - Wang, Wei

AU - Li, Lin

AU - Yu, Changmin

PY - 2022/9

Y1 - 2022/9

N2 - Well-developed mitochondria-targeted nanocarriers for function regulation are highly desirable. Numerous studies have been conducted on the treatment of mitochondria-related diseases; however, further improvements are required to develop more effective drug delivery methods. Herein, we comprehensively introduce recent developments progress in rational design of mitochondria-targeted nanocarriers, and discuss the different strategies of available nanocarriers for targeting mitochondria. We also highlight the advantages and disadvantages of various carrier systems that are currently in use. Finally, perspective on new generation for mitochondria-targeted delivery systems in the emerging area of drug-based therapeutics is also discussed.

AB - Well-developed mitochondria-targeted nanocarriers for function regulation are highly desirable. Numerous studies have been conducted on the treatment of mitochondria-related diseases; however, further improvements are required to develop more effective drug delivery methods. Herein, we comprehensively introduce recent developments progress in rational design of mitochondria-targeted nanocarriers, and discuss the different strategies of available nanocarriers for targeting mitochondria. We also highlight the advantages and disadvantages of various carrier systems that are currently in use. Finally, perspective on new generation for mitochondria-targeted delivery systems in the emerging area of drug-based therapeutics is also discussed.

KW - Mitochondria diseases

KW - Mitochondria target

KW - Nanocarriers

KW - Therapeutic drugs

UR - http://www.scopus.com/inward/record.url?scp=85126268138&partnerID=8YFLogxK

U2 - 10.1016/j.cclet.2022.02.047

DO - 10.1016/j.cclet.2022.02.047

M3 - 文章

AN - SCOPUS:85126268138

SN - 1001-8417

VL - 33

SP - 4146

EP - 4156

JO - Chinese Chemical Letters

JF - Chinese Chemical Letters

IS - 9

ER -

Rational design of nanocarriers for mitochondria-targeted drug delivery

摘要

访问文件

其它文件与链接

指纹

引用此